We did not compare raw volumes across groups (for example Alzheimer’s disease compared to healthy controls) but rather we compared differences between groups with age and APOE status, all of whom were segmented with the same method (see Supplementary material for an analysis of potential bias arising for the segmentation of the subfields and why this does not invalidate our results). The gene discussed is APOE; the disease is Alzheimer disease.